Humoral Response after Two Doses of BNT162b2 mRNA Vaccine Has a Role in Predicting Response after Three Doses That Is Related to Plasma HIV Viremia and Nadir CD4+ Cell Count in HIV-Positive Patients

Humoral Response after Two Doses of BNT162b2 mRNA Vaccine Has a Role in Predicting Response after Three Doses That Is Related to Plasma HIV Viremia and Nadir CD4+ Cell Count in HIV-Positive Patients

We investigated the spike IgG levels of HIV+ patients on antiretroviral therapy six months after they received their second dose (T2) and six months after the third dose (T3) of the BNT162b2 mRNA vaccine, as well as the influence of different levels of plasma HIV viremia of overall CD4+ cell count a...

Full description

Bibliographic Details
Main Authors: Monica Basso, Nicole Pirola, Susanna Pascoli, Beatrice Bragato, Antonio Vinci, Marco Iannetta, Francesco Colombo, Nicholas Geremia, Luca Martignago, Maria Cristina Rossi, Ludovica Cipriani, Mario Giobbia, Pier Giorgio Scotton, Saverio Giuseppe Parisi
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Vaccines
Subjects:
HIV infection
BNT162b2 mRNA vaccine
third dose
nadir
HIV residual viremia
trimeric S-protein antigen
Online Access:https://www.mdpi.com/2076-393X/11/1/82

Internet

https://www.mdpi.com/2076-393X/11/1/82

Similar Items